Eventide Asset Management, LLC 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 11:57 am Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | Eventide Asset Management, LLC | 12,773,577 7.300% | 12,773,577 (New Position) | Filing |